Archives—December 2017

World War & the Copper Country: Request for Artifacts

Dear neighbors and community friends of the Copper Country:

In collaboration with Michigan Tech, the Carnegie Museum, and Finlandia University, the committee on “World War & the Copper Country” (WW1CC) is organizing a series of events to be held during 2018 including exhibits and programs to commemorate the Copper Country’s involvement in World War I (1914-1918). As you may know, the United States intervened in the Great War on April 6, 1917 and the Armistice was announced November 11, 1918.

The Carnegie Museum is seeking to borrow artifacts from the community for an exhibit on WWI and the Copper Country to open in September 2018. These might include:

  • personal letters
  • photos, art, postcards
  • poetry or other writings
  • scrapbooks and newspaper clippings
  • WWI-era musical scores
  • military papers and government documents
  • material objects, ephemera, and souvenirs, e.g., military uniform memorabilia, trench art, anti-war items; home front effects such as pins, posters, pamphlets, etc.
  • other

If you have, or you know of a relative, neighbor, or other community member who has any artifacts that we might borrow, or if you have any questions about the project, please reply to Elise Nelson, ww1cc@mtu.edu or forward this message to possible interested persons.

You will find a list of the Copper County men who were known to have served in the war at www1cc.mtu.edu/roll-call. If you have an addition to the names on the list, please send it by email to ww1cc@mtu.edu.

If possible, please help us with outreach by forwarding this email to any listservs that might generate wide interest and participation from the Copper Country community in this project.

We hope to hear from you. Thank you, and happy holidays!

WW1CC committee,
Elise Nelson, Director, Carnegie Museum of the Keweenaw
Sue Collins, Department of Humanities, MTU
Stefka Hristova, Department of Humanities, MTU
Steve Walton, Department of Social Sciences, MTU
Patty Sotirin, Department of Humanities, MTU


DTRA Basic Research Topics

Basic research topics are now open for applications!  On 20 December 2017 the Defense Threat Reduction Agency (DTRA) posted one (1) Broad Agency Announcement (BAA) amendment and one (1) Government Call amendment for the solicitation of basic research proposals.  Note that the basic research topics are published in the Agency’s fundamental research solicitations:

1)  Fundamental Research to Counter Weapons of Mass Destruction BAA:  HDTRA1-14-24-FRCWMD-BAA Amendment 6

–> http://www.grants.gov/web/grants/view-opportunity.html?oppId=275322
If the link does not work:  do a keyword search for ‘dtra’ at www.grants.gov then select the appropriate solicitation link.

2)  Fundamental Research to Counter Weapons of Mass Destruction Government Call:  HDTRA1-16-24-FRCWMD-Call Amendment 2

–> https://www.dtrasubmission.net

**Please carefully review the solicitations for eligibility criteria, application/submission information, and submission deadlines.**

Administrative and technical questions should be sent to the applicable Agency contacts listed within the solicitations.

Sincerely,
Basic Research Program Staff


NIH RFPs

Requests for Applications

  • Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01 – Clinical Trial Not Allowed)
    (RFA-AG-18-022)
    National Institute on Aging
    Application Receipt Date(s): March 28, 2018, by 5:00 PM

  • Consequences of amyloid protein polymorphisms in Alzheimer’s disease (R01 – Clinical Trial Not Allowed)
    (RFA-AG-18-025)
    National Institute on Aging
    Application Receipt Date(s): March 28, 2018, by 5:00 PM

  • Limited Competition: Revision Applications for International Centers of Excellence for Malaria Research (U19 Clinical Trial Optional)
    (RFA-AI-17-044)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): May 30, 2018 , by 5:00 PM

  • Improving Implementation of Seek, Test, Treat and Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01-Clinical Trial Required)
    (RFA-DA-18-017)
    National Institute on Drug Abuse
    Application Receipt Date(s): April 13, 2018 and November 15, 2018, by 5:00 PM

  • Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01- Clinical Trial Not Allowed)
    (RFA-DA-18-023)
    National Institute on Drug Abuse
    Application Receipt Date(s): April 17, 2018 , by 5:00 PM

  • Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)
    (RFA-DK-17-017)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 20, 2018and, by 5:00 PM

  • Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 – Clinical Trial Optional)
    (RFA-DK-17-018)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 20, 2018; February 21, 2019; February 21, 2020, by 5:00 PM

  • Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44- Clinical Trial Not Allowed)
    (RFA-DK-17-029)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 21, 2018, by 5:00 PM

  • Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed)
    (RFA-DK-17-030)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 21, 2018, by 5:00 PM

  • Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01 Clinical Trials Not Allowed)
    (RFA-HL-19-007)
    Application Receipt Date(s): May 2, 2018, by 5:00 PM local time

  • Limited Competition: Clinical Research Sites for MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01-Clinical Trials Not Allowed)
    (RFA-HL-19-008)
    Application Receipt Date(s): May 2, 2018, by 5:00 PM

  • BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 – Clinical Trial Required)
    (RFA-NS-18-021)
    Application Receipt Date(s): February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM

  • BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required)
    (RFA-NS-18-022)
    Application Receipt Date(s): February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, by 5:00 PM

  • BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 – Clinical Trial Required)
    (RFA-NS-18-023)
    Application Receipt Date(s): February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM

  • Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed)
    (RFA-RM-17-025)
    The Common Fund/Office of Strategic Coordination
    Application Receipt Date(s): March 2, 2018, by 5:00 PM

  • Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trials Not Allowed)
    (RFA-RM-17-027)
    The Common Fund/Office of Strategic Coordination
    Application Receipt Date(s): March 2, 2018, by 5:00 PM

  • Microphysiological Systems Data Center U24 (Clinical Trial Not Allowed)
    (RFA-TR-18-005)
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): March 21, 2018, by 5:00 PM

  • NextGen Tissue Chip Testing Centers: Validating Microphysiological Systems (U24 Clinical Trial Not Allowed)
    (RFA-TR-18-006)
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): March 21, 2018, by 5:00 PM

  • Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed)
    (RFA-TW-17-001)
    John E. Fogarty International Center
    Application Receipt Date(s): March 28, 2018, by 5:00 PM

Program Announcements

  • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional)
    (PA-18-347)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional)
    (PA-18-348)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Self-Management for Health in Chronic Conditions (R01 Clinical Trial Optional)
    (PA-18-376)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional)
    (PA-18-377)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Community Partnerships to Advance Research (CPAR) (R21 Clinical Trial Optional)
    (PA-18-381)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Self-Management for Health in Chronic Conditions (R21 Clinical Trial Optional)
    (PA-18-384)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed)
    (PA-18-471)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Personalized Strategies to Manage Symptoms of Chronic Illness (R15 Clinical Trial Not Allowed)
    (PA-18-472)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed)
    (PA-18-473)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed)
    (PA-18-474)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed)
    (PA-18-475)
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 – Clinical Trial Optional)
    (PA-18-507)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM.  The first due date for this FOA is June 5, 2018

  • Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 – Clinical Trial Optional)
    (PA-18-508)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp – Clinical Trial Not Allowed)
    (PA-18-517)
    Application Receipt/Submission Date(s): March 5, 2018, by 5:00 PM local time of applicant organization.

  • Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
    (PA-18-525)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.

  • Early-life Factors and Cancer Development Later in Life (R01 – Clinical Trial Not Allowed)
    (PA-18-529)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM

  • Early-life Factors and Cancer Development Later in Life (R03 – Clinical Trial Not Allowed)
    (PA-18-531)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Early-life Factors and Cancer Development Later in Life (R21 – Clinical Trial Not Allowed)
    (PA-18-532)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply), by 5:00 PM

  • Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 – Clinical Trial Optional)
    (PA-18-545)
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trials Not Allowed)
    (PAR-18-505)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 – Clinical Trial Optional)
    (PAR-18-506)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional )
    (PAR-18-509)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM

  • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
    (PAR-18-510)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply ), by 5:00 PM

  • Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 – Clinical Trial Optional)
    (PAR-18-511)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
    (PAR-18-512)
    National Institute on Aging
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates.

  • Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
    (PAR-18-513)
    National Institute on Aging
    Application Receipt/Submission Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequently, standard dates apply, by 5:00 PM

  • Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
    (PAR-18-514)
    National Institute on Aging
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates.

  • Human Cell Biology of Alzheimer’s Disease Genetic Variants (R01 – Clinical Trial Not Allowed)
    (PAR-18-516)
    National Institute on Aging
    Application Receipt/Submission Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequent due dates for new applications: June 8, 2018; October 9, 2018; February 8, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 7, 2020; and October 7, 2020, by 5:00 PM local time of the applicant organization. Due dates for resubmission and revision applications: July 9, 2018; November 7, 2018; March 7, 2019; July 7, 2019; November 7, 2019; March 7, 2020; July 7, 2020; and November 7, 2020 , by 5:00 PM local time of applicant organization

  • Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 – Clinical Trial Not Allowed)
    (PAR-18-519)
    National Institute on Aging
    Application Receipt/Submission Date(s): New: March 26, 2018; June 6, 2018; October 7, 2018; February 7, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 8, 2020; and October 8, 2020, by 5:00 PM local time of the applicant organization. Resubmission/Revision: July 7, 2018; November 7, 2018; March 7, 2019; July 8, 2019; November 7, 2019; March 6, 2020; July 7, 2020; and November 6, 2020, by 5:00 PM

  • NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
    (PAR-18-521)
    National Eye Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
    (PAR-18-522)
    National Eye Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • NEI Collaborative Clinical Vision Research : Chair’s Grant (UG1-Clinical Trial Required)
    (PAR-18-523)
    National Eye Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease and AD Related Dementias (T32 – Clinical Trial Not Allowed)
    (PAR-18-524)
    National Institute on Aging
    Application Receipt/Submission Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequently, standard dates apply, by 5:00 PM

  • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
    (PAR-18-527)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM

  • NeuroNEXT Clinical Trials (U01 – Clinical Trial Optional)
    (PAR-18-528)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM

  • Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Optional)
    (PAR-18-530)
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt/Submission Date(s): The first due date for all types of applications allowed for this FOA is March 8, 2018. Thereafter Standard dates apply, by 5:00 PM

  • NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional)
    (PAR-18-533)
    National Institute on Deafness and Other Communication Disorders
    Application Receipt/Submission Date(s): June 19, 2018; February 20, 2019; October 18, 2019; June 18, 2020; February 22, 2021, by 5:00 PM

  • Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)
    (PAR-18-534)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): February 15, 2018; August 17, 2018, by 5:00 PM

  • Basic and Translation Research on Decision Making in Aging and Alzheimer’s Disease (R21 – Clinical Trial Optional)
    (PAR-18-538)
    National Institute on Aging
    Application Receipt/Submission Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequent due dates are June 20, 2018; February 20, 2019; June 20, 2019; February 20, 2020; and June 22, 2020, by 5:00 PM

  • International Research Scientist Development Award (IRSDA) (K01) – Independent Clinical Trial Not Allowed
    (PAR-18-539)
    John E. Fogarty International Center
    National Cancer Institute
    Application Receipt/Submission Date(s): March 7, 2018; March 7, 2019; March 6, 2020, by 5:00 PM local time

  • International Research Scientist Development Award (IRSDA) (K01) – Independent Clinical Trial Required
    (PAR-18-540)
    John E. Fogarty International Center
    National Cancer Institute
    Application Receipt/Submission Date(s): March 7, 2018; March 7, 2019; March 6, 2020, by 5:00 PM

  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) – Clinical Trial Optional
    (PAR-18-541)
    Application Receipt/Submission Date(s): February 7, 2018, August 9, 2018, February 9, 2019, August 9, 2019, February 11, 2020, by 5:00 PM local time of applicant organization.

  • NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 – Clinical Trial Optional)
    (PAR-18-542)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, and July 20, 2020), by 5:00 PM

  • CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional)
    (PAR-18-543)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, and July 20, 2020 , by 5:00 PM

  • Basic and Translational Research on Decision Making in Aging and Alzheimer’s Disease (R01 – Clinical Trial Optional)
    (PAR-18-544)
    National Institute on Aging
    Application Receipt/Submission Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequent due dates are June 8, 2018; February 8, 2019; June 8, 2019; February 7, 2020; and June 8, 2020, by 5:00 PM l

  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) – Clinical Trial Optional
    (PAR-18-546)
    Application Receipt/Submission Date(s): February 7, 2018, August 9, 2018, February 9, 2019, August 9, 2019, February 11, 2020, by 5:00 PM

  • NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) – Clinical Trial Required
    (PAR-18-547)
    National Institute of Dental and Craniofacial Research
    Application Receipt/Submission Date(s): New applications – February 23, June 6, and October 4 of 2018; February 6, June 6 and October 8 of 2019; February 6, June 8, and October 6 of 2020 by 5:00 PM local time of applicant organization. Revised applications – July 6 and November 6 of 2018; March 6, July 8 and November 6 of 2019; March 6, July 7 and November 6 of 2020, by 5:00 PM

  • Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 – Clinical Trial Optional)
    (PAR-18-548)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): March 14, 2018; July 18, 2018; February 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5:00 PM local time of applicant organization.

  • Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 – Clinical Trial Optional)
    (PAR-18-549)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): March 14, 2018; July 18, 2018; February 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5:00 PM
  • Analytical Validation of Candidate Biomarkers for Neurological Disease (U01 Clinical Trial Optional)
    (PAR-18-550)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): March 14, 2018; July 18, 2018; February, 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5:00 PM

  • Partnership for Aging and Cancer Research (U01 – Clinical Trial Not Allowed)
    (PAR-18-552)
    National Cancer Institute
    National Institute on Aging
    Application Receipt/Submission Date(s): June 8, 2018, by 5:00 PM 

Strategic Plan: Final draft, provide feedback.

The Strategic Plan describes the priorities for the next five years that must be addressed in order to advance toward the Portrait of 2045. The Strategic Plan is revised every three years and feedback was collected at the beginning of the academic year to begin the revision process. Thank you to everyone who submitted feedback during the open comment period.
The final draft of the Plan has been posted and the Vice President for Research is seeking feedback from the community once again. Suggestions and comments are welcomed and your feedback is anonymous.
If you would like to leave feedback, do so at the following link: Strategic Plan Feedback.

NIH Applicant Assistant Program due Jan. 15

NIH Applicant Assistance Program (AAP)

Apply today HERE

Application deadlines:

JANUARY 15, 2018 for New Applications
FEBRUARY 5, 2018 for Re-submissions
APRIL 5, 2018 for Grant Submission

Newly announced, the NIH Applicant Assistance Program (AAP) is a pilot program to assist eligible small businesses in understanding and completing the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process. AAP is intended to help new and/or previously unsuccessful small businesses submit a competitive SBIR or STTR application to one of the participating institutes (NCI, NINDS, NHLBI).

NIH is particularly interested in assisting small businesses that are owned or operated by individuals who are underrepresented in the biomedical sciences, including:

  • Black or African Americans
  • Hispanics or Latinos
  • American Indians or Alaska Natives
  • Native Hawaiians and other Pacific Islanders
  • Individuals with disabilities
  • Women (underrepresented in biomedical industry ownership and high-level leadership)

For more information on how to apply, please read the full Notice: NOT-CA-18-031


MTRAC Funding Opportunity Informational Meetings

Michigan Tech’s Office of Innovation and Industry Engagement reminds all faculty researchers that the deadline for submitting a Letter of Intent for the second round of its Michigan Translational Research and Commercialization (MTRAC) Innovation Hub program is Jan. 19. Two informational meetings on the program and developing a letter of intent are open to interested faculty. The first will be held at 3:30 p.m. Tuesday, Jan. 9 in M&M 724.

The second meeting is scheduled for 3:30 p.m. Wednesday Jan. 17 in EERC 501. Both meetings can be attended virtually via Zoom.

The MTRAC Innovation Hub grant from the Michigan Economic Development Corporation program sponsors collaborative translational research projects led by teams of researchers and business advisors as needed working in the area of advanced applied materials. The mission of this program is to develop technologies that address unmet or poorly met market needs.

Examples of desirable translational research goals and outcomes include achieving specific milestones on the path to commercializing systems, materials, processing technologies or devices which serve a well-documented market need. Proposals may address proof of concept demonstration, prototype development or process scale up that is necessary to attract follow-on funding from third parties.

Projects of up to $100,000 (including 1:1 matching funds) can be approved but additional commercialization value is likely to be found through collaboration with the program’s outside Oversight Committee. The program is open to researchers at all Michigan public universities, hospitals and non-profit research institutes.

The proposal must relate to an innovative technology previously disclosed to Michigan Tech’s office of Innovation and Industry Engagement through the invention disclosure process. The PI must be willing to become involved in the initial business development activities such as customer discovery, competitive analysis, follow-on funding development and assessment of the intellectual property landscape surrounding the technology.

The application process begins with a one page letter of intent due Friday, Jan. 19 which should be emailed by 6 p.m. that day to Program Director Brenda Da Costa

Applicants are advised to consult with John Diebel or Da Costa on proposal and budget development. Proposals accepted by the Oversight Committee will be invited to submit a more detailed proposal in late March. The final step in the selection process is an invited oral presentation to the Oversight Committee in late May. Details of the application process can be found online.


ORAU RFPs and Opportunities

University Partnerships Office (UPO) Annual Program Opportunities and Deadlines

One of the benefits of membership in the ORAU University Consortium is funding opportunities available only to member universities.  The following is a list of UPO’s FY 2018 program/event opportunities and deadlines.  All programs are subject to available funding and expect to be continued for future years. Questions on any of these programs should be addressed to university.partnerships@orau.org.

Ralph E. Powe Junior Faculty Enhancement Awards

http://www.orau.org/university-partnerships/faculty-student-programs/powe/default.aspx

The Ralph E. Powe Junior Faculty Enhancement Awards provide seed money for research by junior faculty at ORAU member institutions. These awards are intended to enrich the research and professional growth of young faculty and result in new funding opportunities. The deadline for applications for the FY 2018 awards is Monday, January 8, at noon EST. Each ORAU member councilor may submit up to two applications each year. All applications must be received electronically at PoweAwards@orau.org. Fax submittals will not be accepted.

73rd Annual Meeting of the ORAU Council of Sponsoring Institutions – Registration Reminder

https://www.orau.org/council/

Please register to attend the 2018 Annual Meeting of the Council of Sponsoring Institutions that will be held Tuesday, March 6th through Thursday, March 8th, 2018.  ORAU’s 73rd Annual Meeting of the Council of Sponsoring Institutions will be focused on “Public Health Security and Biological Threats.” The meeting will focus on the issues related to preparedness for bioterrorism and other major public health threats.  Your participation will provide an opportunity for you and your colleagues to discuss key science and technology challenges and opportunities. Experts and leaders from academia and federal agencies will share their views on the effective strategies for continued progress in areas of national importance for global health security.  Visit the 73rd Annual Meeting of the Council of Sponsoring Institutions official website to view the agenda and featured speakers as well as complete your registration. Please designate a proxy to attend if you are unable to attend.  Due to security requirements, registration for non-US Citizens closes on February 6, 2018 and registration for US Citizens closes on February 13, 2018.  If you have any questions send an email to university.partnerships@orau.org.

ORAU-Directed Research and Development Program:  Phase 2 Deadline March 26, 2018

The deadline for the ORAU-Directed Research and Development (ODRD) Program Phase 2 joint ORAU/university proposal submissions is March 26, 2018.  As a reminder, ODRD projects are joint collaborations consisting of innovative research-based approaches/solutions that fall within the intersection of ORAU’s core capabilities and our member universities research interests.

Universities may propose ODRD Concepts for potential collaboration with an ORAU subject matter expert (SME).  University ODRD concepts are vetted by each school’s ORAU Councilor and submitted on the Value Through Partnerships External SharePoint Site:    https://upo.orau.org/Partners/default.aspx.  Research concepts need to be submitted as early as possible to provide sufficient time to develop the joint proposals.

After matching interests, Phase 1 and Phase 2 applications are submitted by the ORAU SME, on behalf of the collaboration team.  Phase 1 participation is not a requirement for Phase 2.  Phase 1 travel grants are considered on an on-going basis.

For additional program information, please visit the ODRD Program page on the ORAU website:   http://www.orau.org/university-partnerships/members-only/odrd/default.aspx


Notice of Upcoming PCORI Funding Announcement 

This advance notice encourages research institutions with expertise and experience in clinical comparative effectiveness research (CER)/patient-centered outcomes research (PCOR), and communication and dissemination research to consider sending research applications in response to the upcoming Patient-Centered Outcomes Research Institute (PCORI) Funding Announcement (PFA) to be released on January 16, 2018.

Well-documented barriers exist to the rapid transfer of evidence. To facilitate well-informed healthcare decision making, innovative and effective strategies are required to make existing PCOR/CER evidence available to patients and providers in real-world settings. Moreover, the information needs to be understandable to improve decision making.

Clear communication approaches and active dissemination of PCOR/CER research findings to all audiences (in easy-to-understand formats) are critical to increasing the awareness, consideration, adoption, and use of these data by patients, caregivers, and healthcare providers. This priority area focuses on three key areas: communication strategies, dissemination strategies, and strategies for explaining uncertainty.

The preannouncement of this PFA is provided to allow potential applicants additional time to identify collaborators, obtain stakeholder input on the research question and design, and develop responsive, high-quality applications.

Key Information
Status: Upcoming Cycle: Cycle 1 2018
Full Announcement: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; Communication and Dissemination Research; and Improving Healthcare Systems (Broad) Announcement Type: Research Award
Online System Opens: January 16, 2018 Applicant Town Hall Session: February 1, 2018
Letter of Intent (LOI) Deadline: February 13, 2018 Application Deadline: May 16, 2018
Merit Review: August 2018 Awards Announced: November 20, 2018
Total Direct Costs: Not to exceed $2 million per project Maximum Project Period: 3 years
Funds Available Up To: $8 million Earliest Start Date: January 2019

 

 

 

 

 

 

 

 

 

 

 

 

 


MSBDC: Fundamentals of Small Business Success

The Michigan SBDC has redesigned our online training series
“The Fundamentals of Small Business Success”
launching January 17th
Each week we’ll cover an important business topic, with time reserved for live Q&A with a Michigan SBDC business consultant. Have your questions ready – it’s like a virtual coffee meeting with a business expert!
Webinars include:
+ Starting a Business
+ Writing a Business Plan
+ Marketing Your Business
+ Financial Management
+ Business Legal Issues
The Fundamentals webinars are available at no-cost to Michigan-based entrepreneurs. We know you’re busy, so hop online and let us help you focus on the foundations of your business.

ORAU Opportunities with due dates in Dec & Jan

The ORAU University Partnerships Office is pleased to provide the following information, available to all institutions.  Please forward within your institution and broadly to colleagues as you feel appropriate.

IACMI – The Composites Institute 2018 Internship Program

http://www.orau.org/IACMI/

The Institute for Advanced Composite Manufacturing Innovation (IACMI) is currently seeking graduate and undergraduate students interested in participating in a 10-week summer program at one of IACMI’s partner sites.  IACMI, which accelerates the adoption of advanced composites to create energy savings and new manufacturing jobs, has an interest in developing the skills of strong technical undergraduates who might one day support the workforce in both talent and leadership. Interested applicants have the opportunity to apply for internships specializing in various composite and materials research in five technology areas at one of IACMI’s partner locations.  In addition to being involved in a variety of IACMI partner activities, during the course of their internship, participants will have the opportunity to use state-of-the-art equipment and interact with scientists and engineers who are at the top of their fields. Engaging in hands-on learning that is more project-based than traditional academic coursework is a critical way to learn and refine skills.  The application deadline is Sunday, December 31st, 2017.  For additional information, visitwww.orau.org/IACMI or email Julie Malicoat at julie.malicoat@orau.org.

DOE Solar Energy Innovators Program

https://www.zintellect.com/Posting/details/3717

The Solar Energy Innovators Program is seeking applicants interested in researching innovative solutions to the challenges faced by utilities, energy service providers, and public utilities commissions (PUCs) to adapt to a system with increasing levels of solar and other distributed energy resources. Innovators selected for the program will conduct hands-on, practical research and development on-site at a utility, energy service provider, or PUC host institution.  The Solar Energy Innovators Program is sponsored by the U.S. Department of Energy (DOE) Office of Energy Efficiency & Renewable Energy (EERE), Solar Energy Technology Office (SETO).  The application deadline is Monday, January 8, 2018 at 11:59 PM EST.  For questions call Taylor Pitchford at 865-574-4806 or email at DOE-RPP@orau.org. 

2018 Summer ORISE Fellowship Opportunity at CDC

https://www.zintellect.com/Posting/details/3727

A summer fellowship opportunity is available in the Division of Laboratory Sciences (DLS) within the National Center for Environmental Health (NCEH) at the Centers for Disease Control and Prevention (CDC) on the Chamblee Campus in Atlanta, Georgia.  DLS provides laboratory support that improves the detection, diagnosis, treatment, and prevention of environmental, tobacco-related, nutritional, newborn, selected chronic and selected infectious diseases. DLS also works to improve the rapid and accurate detection of chemical threat agents, radiologic threat agents, and selected toxins.  Collaborating with a multidisciplinary team, the selected participant will use state-of-the-art laboratory equipment to address topics relevant to public health.  This will allow the participant to gain hands-on experience in applied analytical chemistry and enhance their knowledge of its applications to public health.  The application deadline is Friday, January 19, 2018 at 3:00 PM EST.  If you have questions, send an email to CDCrpp@orau.org.  Please include reference code CDC-NCEH-2018-0013 in your email.

2018 Summer Faculty Opportunities at Oak Ridge National Laboratory

ORNL is the largest U.S. Department of Energy science and energy laboratory, conducting basic and applied research to deliver transformative solutions to compelling problems in energy and security.  Visit http://www.youtube.com/watch?v=NSCdUJ8cavw to discover some exciting reasons why ORNL offers great research opportunities!

In addition to the research, these experiences provide access to scientific seminars, facility tours and other networking events.  Both programs also provide eligible faculty members an opportunity to invite students to apply to participate on the research project.  Selected faculty members and students participate for 10-week summer research appointments.  The summer appointment dates are June 4 – August 10, 2018.

Program Name Eligibility Application Deadline and  Informational Website
DOE Office of Science’s Office of Workforce Development for Teachers and Scientists Visiting Faculty Program (VFP) ·         U.S. citizen or Legal Permanent Resident

·         Full-time faculty member in physics, chemistry, biology (non-medical), math, engineering, environmental sciences, materials sciences, or computer or computational sciences at an accredited U.S. institution historically underrepresented in the U.S. research community

·         5PM ET on January 12, 2018

·         http://science.energy.gov/wdts/vfp/

HBCU/MEI Summer Faculty Research Program ·         No citizenship requirement, unless specified

·         Full-time faculty member at institutions of higher learning that are designated by the federal government as HBCUs, Hispanic-Serving Institutions, Tribal Colleges, or Alaska Native or Native Hawaiian Serving Institutions

·         11:59PM ET on February 9, 2018

·         http://www.orau.org/ornl/faculty/hbcu-mei-summer-program.htm

Please contact Julie Malicoat at Julie.Malicoat@orau.org for additional information.

ORAU

University Partnerships Office

University.partnerships@orau.org

www.orau.org

ORAU provides innovative scientific and technical solutions to advance research and education, protect public health and the environment, and strengthen national security. Through specialized teams of experts, unique laboratory capabilities and access to a consortium of more than 100 major Ph.D.-granting institutions, ORAU works with federal, state, local and commercial customers to advance national priorities and serve the public interest. A 501(c)(3) nonprofit corporation and federal contractor, ORAU manages the Oak Ridge Institute for Science and Education (ORISE) for the U.S. Department of Energy (DOE).